Viking Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	100.38	26.68	55.52	36.63	26.37	29.12
Short-Term Investments	614.19	875.94	306.56	118.85	175.73	219.27
Cash & Short-Term Investments	714.57	902.61	362.08	155.49	202.1	248.39
Cash Growth	-23.20%	149.29%	132.87%	-23.07%	-18.63%	-9.89%
Prepaid Expenses	2.24	1.13	2.52	3.41	0.62	0.44
Other Current Assets	21.89	3.48	2.62	8.14	7.81	7.28
Total Current Assets	738.7	907.22	367.23	167.04	210.53	256.1
Property, Plant & Equipment	0.67	1	1.13	1.42	0.03	0.32
Long-Term Deferred Charges	-	0.06	0.11	0.04	0.08	0.05
Other Long-Term Assets	0.05	0.05	0.03	0.03	0.03	0.03
Total Assets	739.42	908.32	368.49	168.53	210.66	256.5
Accounts Payable	4.41	9.81	7.51	8.53	1.44	3.99
Accrued Expenses	21.22	17.11	11.3	13.11	7.31	7.81
Current Portion of Leases	0.44	0.49	0.32	0.3	0.03	0.33
Total Current Liabilities	26.07	27.41	19.14	21.95	8.78	12.13
Long-Term Leases	0.32	0.63	0.94	1.26	-	0.03
Total Liabilities	26.39	28.04	20.07	23.21	8.78	12.16
Common Stock	0	0	0	0	0	0
Additional Paid-In Capital	1,403	1,369	733.55	445.27	425.61	412.59
Retained Earnings	-689.88	-487.91	-377.94	-292.05	-223.18	-168.19
Treasury Stock	-	-	-6.8	-6.8	-	-
Comprehensive Income & Other	0.37	-0.79	-0.39	-1.1	-0.55	-0.05
Shareholders' Equity	713.03	880.28	348.42	145.32	201.88	244.34
Total Liabilities & Equity	739.42	908.32	368.49	168.53	210.66	256.5
Total Debt	0.76	1.12	1.26	1.56	0.03	0.36
Net Cash (Debt)	713.82	901.49	360.82	153.92	202.07	248.03
Net Cash Growth	-23.18%	149.85%	134.42%	-23.83%	-18.53%	-9.80%
Net Cash Per Share	6.37	8.27	3.82	2.00	2.62	3.42
Filing Date Shares Outstanding	113.04	112.25	100.49	78.42	78.36	74.13
Total Common Shares Outstanding	112.45	111.57	100.11	78.26	78.25	73.22
Working Capital	712.64	879.8	348.09	145.09	201.75	243.98
Book Value Per Share	6.34	7.89	3.48	1.86	2.58	3.34
Tangible Book Value	713.03	880.28	348.42	145.32	201.88	244.34
Tangible Book Value Per Share	6.34	7.89	3.48	1.86	2.58	3.34

Source: S&P Global Market Intelligence. Standard template. Financial Sources.